Trial Profile
Tenofovir for the treatment of chronic hepatitis B: a study of efficacy and safety in clinical practice in NUC naive or IFN experienced patients.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 31 Jul 2011
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms Ten-B
- 31 Jul 2011 New trial record